Karras Company Inc. Purchases New Shares in Merit Medical Systems, Inc. $MMSI

Karras Company Inc. purchased a new stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 11,525 shares of the medical instruments supplier’s stock, valued at approximately $1,016,000. Merit Medical Systems comprises about 1.0% of Karras Company Inc.’s holdings, making the stock its 28th biggest holding.

Other institutional investors and hedge funds have also bought and sold shares of the company. Maseco LLP purchased a new stake in Merit Medical Systems in the 4th quarter valued at $26,000. Torren Management LLC purchased a new stake in Merit Medical Systems in the 4th quarter valued at $38,000. Covestor Ltd raised its position in Merit Medical Systems by 252.6% in the 4th quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock valued at $41,000 after buying an additional 336 shares during the last quarter. Danske Bank A S purchased a new stake in Merit Medical Systems in the 3rd quarter valued at $42,000. Finally, Quarry LP raised its position in Merit Medical Systems by 185.9% in the 3rd quarter. Quarry LP now owns 526 shares of the medical instruments supplier’s stock valued at $44,000 after buying an additional 342 shares during the last quarter. 99.66% of the stock is owned by hedge funds and other institutional investors.

Merit Medical Systems Stock Up 0.8%

Shares of NASDAQ:MMSI opened at $64.17 on Friday. The company has a market capitalization of $3.83 billion, a PE ratio of 27.78, a price-to-earnings-growth ratio of 1.98 and a beta of 0.58. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.08 and a quick ratio of 3.46. The business has a fifty day moving average price of $66.86 and a two-hundred day moving average price of $77.79. Merit Medical Systems, Inc. has a 1 year low of $59.74 and a 1 year high of $97.18.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.10. The firm had revenue of $381.88 million during the quarter, compared to the consensus estimate of $377.59 million. Merit Medical Systems had a return on equity of 13.54% and a net margin of 9.03%.The business’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.86 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Analysts forecast that Merit Medical Systems, Inc. will post 3.61 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Barrington Research lowered their price target on Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating for the company in a research report on Monday, April 20th. Needham & Company LLC lowered their price target on Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating for the company in a research report on Friday, May 1st. BTIG Research assumed coverage on Merit Medical Systems in a research report on Friday, February 6th. They issued a “buy” rating and a $107.00 price target for the company. Canaccord Genuity Group lowered their price target on Merit Medical Systems from $90.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Finally, Citigroup reissued an “outperform” rating on shares of Merit Medical Systems in a research report on Monday, April 20th. Eight analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $92.80.

Insiders Place Their Bets

In other Merit Medical Systems news, insider Brian G. Lloyd acquired 2,000 shares of Merit Medical Systems stock in a transaction on Thursday, May 7th. The stock was purchased at an average price of $62.62 per share, for a total transaction of $125,240.00. Following the purchase, the insider directly owned 2,000 shares of the company’s stock, valued at $125,240. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Lynne N. Ward sold 5,000 shares of the company’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $62.61, for a total value of $313,050.00. Following the completion of the transaction, the director owned 7,809 shares of the company’s stock, valued at $488,921.49. This trade represents a 39.04% decrease in their position. The SEC filing for this sale provides additional information. 0.70% of the stock is owned by corporate insiders.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.